Companies
Arrowhead Pharmaceuticals Inc [ARWR] fell -39.63% so far this year. What now?
Arrowhead Pharmaceuticals Inc [NASDAQ: ARWR] price plunged by -11.81 percent to reach at -$1.52. The one-year ARWR stock forecast points to a potential upside of 74.87. The average equity rating for ARWR stock is currently 1.57, trading closer to a bullish pattern in the stock